Multidimensional assessment of adverse events of bupropion: A large-scale data analysis from the FAERS database Rongrong Lu, Ying Jiang, Zhiqiang Du, Qin Zhou, Yuan Shen, Haohao Zhu Journal of Affective Disorders.2024; 354: 649. CrossRef
Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso BMC Neurology.2022;[Epub] CrossRef
Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence Thomas Müller Journal of Experimental Pharmacology.2021; Volume 13: 397. CrossRef